XYL
49
4
CL
58
2
IBM
58
-2
SEE
56
6
PG
56
5
BK
74
2
STI
14
-17
DRI
53
5
TJX
64
2
PNC
64
4
PRGO
39
3
NWL
53
3
PVH
62
5
A
43
2
CRM
67
2
ES
34
3
SCHW
62
-2
ORLY
62
2
MSFT
50
3
BMY
60
2
XYL
49
4
CL
58
2
IBM
58
-2
SEE
56
6
PG
56
5
BK
74
2
STI
14
-17
DRI
53
5
TJX
64
2
PNC
64
4
PRGO
39
3
NWL
53
3
PVH
62
5
A
43
2
CRM
67
2
ES
34
3
SCHW
62
-2
ORLY
62
2
MSFT
50
3
BMY
60
2
Financhill
Back

Colgate-Palmolive 10K Form

Buy
58

CL
Colgate-Palmolive

Last Price:
94.89
Seasonality Move:
2.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CL News And Ratings

See the #1 stock for the next 7 days that we like better than CL

CL Financial Statistics

Sales & Book Value

Annual Sales: $19.46B
Cash Flow: $1.03B
Price / Cash Flow: 23.01
Annual Sales: $0.53
Price / Book: 178.28

Profitability

EPS (TTM): 3.49000
Net Income (TTM): $2.87B
Gross Margin: $11.33B
Return on Equity: 434.96%
Return on Assets: 17.44%

Colgate-Palmolive Earnings Forecast

Key Colgate-Palmolive Financial Ratios

  • The Gross Profit Margin over the past 40 years for CL is 58.21%.
  • The Selling, General & Administrative Expenses for CL have been equal to 36.75% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 12.48% of Operating Income.
  • The Net Earning history of CL is 11.82% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 26 years.

Colgate-Palmolive Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Household Products
Sector: Consumer Staples
Current Symbol: CL
CUSIP: 194162
Website: colgatepalmolive.com

Debt

Debt-to-Equity Ratio: 19.39
Current Ratio: 1.04
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 34.27
Forward P/E Ratio: 24.58

CL Technical Analysis vs Fundamental Analysis

Buy
58
Colgate-Palmolive (CL) is a Buy

Is Colgate-Palmolive a Buy or a Sell?

  • Colgate-Palmolive stock is rated a Buy
    The current Colgate-Palmolive [CL] share price is $94.92. The Score for CL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.